Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:18:2438-46.
Epub 2012 Oct 4.

Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy

Affiliations

Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy

Huiqin Yang et al. Mol Vis. 2012.

Abstract

Purpose: To identify mutations in FZD4 and LRP5 in 49 Chinese families with familial exudative vitreoretinopathy (FEVR) and to reveal the mutation spectrum and frequency of these genes in the Chinese population.

Methods: Clinical data and genomic DNA were collected for patients from 49 families with FEVR. The coding exons and adjacent intronic regions of FZD4 and LRP5 were amplified with polymerase chain reaction, and the resulting amplicons were analyzed with Sanger sequencing.

Results: Eleven mutations were detected in 11 of the 49 families (22.4%), including five mutations in the FZD4 gene in six families and six mutations in the LRP5 gene in five families. Of the 11 mutations, eight were novel. Two families had the same FZD4 mutation, and one family had compound heterozygous mutations in LRP5. The phenotypes of the patients with the mutations showed great variability.

Conclusions: Our findings provide an overview of the mutation spectrum and frequency of FZD4 and LRP5 in Chinese patients with FEVR and emphasize the complexity of FEVR mutations and phenotypes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Eleven mutations identified in FZD4 and LRP5 genes of 49 families with FEVR. The columns from left to right display the family number, the mutation designation, and sequence chromatography from patients and normal controls.
Figure 2
Figure 2
Pedigrees of 11 families with FZD4 or LRP5 mutations. A + sign represents a normal allele, and a - sign indicates a variant. The proband in family QT191 had compound heterozygous mutation, while his mother had a heterozygous c.2484C>G: variant and his father had a heterozygous c.2626G>A variant. The squares brackets around II:1 in family QT476 indicated an adopted proband.
Figure 3
Figure 3
Protein alignment for the novel missense mutations identified in FZD4 and LRP5. Nonconserved amino acid residues are boxed. The residues with mutations are highly conserved. FZD4 orthologs included Homo sapiens (NP_036325.2), Pan troglodytes (XP_001175326.1), Mus musculus (NP_032081.2), Rattus norvegicus (NP_072145.1), Bos taurus (NP_001193198.1), Equus caballus (XP_001489854.1), Canis familiaris (XP_848753.1), Gallus gallus (NP_989430.1), and Danio rerio (XP_002664771.1). The LRP5 orthologs are from Homo sapiens (NP_002326.2), Pan troglodytes (XP_508605.2), Mus musculus (NP_032539.1), Rattus norvegicus (NP_001099791.2), Bos taurus (XP_614220.3), Gallus gallus (NP_001012915.1), and Danio rerio (NP_001170929.1).
Figure 4
Figure 4
Ocular changes in affected individuals with an FZD4 or LRP5 mutation. The individual ID is indicated on the top left of each picture, which is the same as in Figure 2 and Table 2. Signs of FEVR included retinal detachment (top left), falciform retinal fold (top middle), temporal dragging of optic disc (top right), peripheral avascular zone and brush-like peripheral vessels (middle left), shell-like peripheral vessel terminatio and neovascularization (center), peripheral fibrovascular proliferation (middle right), lens dislocation (bottom left), peripheral exudates (bottom middle), temporal dragging of optic disc, and peripheral fibrous proliferation (bottom right).

References

    1. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68:578–94. - PubMed
    1. van Nouhuys CE. Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy. Am J Ophthalmol. 1991;111:34–41. - PubMed
    1. Ober RR, Bird AC, Hamilton AM, Sehmi K. Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol. 1980;64:112–20. - PMC - PubMed
    1. Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet. 2002;32:326–30. - PubMed
    1. Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GC, Downey LM, Zhang K, Inglehearn CF. Mutations in lrp5 or fzd4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721–30. - PMC - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources